Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis

Summary

This is a research study. The over-the-counter (OTC) drug for atopic dermatitis being tested is not approved as a treatment for the participants' atopic dermatitis condition. In participating in this study, the investigators will analyze the participants' skin microbiome, measure skin hydration and barrier function, and assess clinical improvements to help us understand the potential impact of the investigational OTC drug on atopic dermatitis and skin microbiome balance.

Timeline

Start

2025-08-14

Primary completion

2026-05-12

Completion

2026-05-12

Outcome

Outcome not reported

Stopped (Enrollment): “We have decided to close the study due to recruitment challenges.”

Drugs

Indications